Marc Ferrer Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2019	Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors.
11/2017	Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Ferrer Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 12/2006
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
7	Infections 05/2021 - 04/2015
5	Inflammation (Inflammations) 12/2022 - 09/2009
5	ST Elevation Myocardial Infarction 12/2022 - 12/2017
5	Ovarian Neoplasms (Ovarian Cancer) 08/2021 - 01/2017
5	Breast Neoplasms (Breast Cancer) 11/2018 - 12/2003
5	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 05/2005
4	Virus Diseases (Viral Diseases) 01/2022 - 12/2019
4	COVID-19 01/2022 - 06/2020
4	Melanoma (Melanoma, Malignant) 01/2020 - 01/2013
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019 - 01/2018
3	Rhabdomyosarcoma 01/2018 - 01/2017
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2016 - 01/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2014 - 06/2012
2	Ventricular Fibrillation 12/2022 - 01/2018
2	Neurofibrosarcoma (MPNST) 01/2022 - 07/2020
2	Human Influenza (Influenza) 05/2021 - 01/2019
2	Carcinogenesis 01/2021 - 01/2017
2	Starvation 01/2020 - 03/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 11/2017
2	Rare Diseases (Rare Disease) 01/2019 - 01/2017
2	Disease Progression 01/2019 - 01/2017
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 09/2016
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 12/2017
2	Mood Disorders (Mood Disorder) 04/2017 - 12/2010
2	Fibrosarcoma 11/2016 - 01/2013
2	Neurologic Manifestations (Neurological Manifestations) 11/2016 - 03/2013
2	Globoid Cell Leukodystrophy (Krabbe Disease) 11/2016 - 03/2013
2	Colonic Neoplasms (Colon Cancer) 10/2016 - 11/2008
2	Leukemia 10/2015 - 01/2013
2	Heart Failure 01/2015 - 01/2013
2	Borderline Personality Disorder (Personality Disorders, Borderline) 10/2014 - 03/2012
2	Insulin Resistance 01/2012 - 03/2009
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2010 - 01/2008

Drug/Important Bio-Agent (IBA)

25	Pharmaceutical PreparationsIBA 01/2022 - 06/2008
20	Proteins (Proteins, Gene)FDA Link 12/2022 - 11/2006
6	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2015
5	Drug CombinationsIBA 12/2020 - 10/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2015
4	Phosphotransferases (Kinase)IBA 01/2021 - 08/2014
4	Peptides (Polypeptides)IBA 11/2019 - 05/2005
4	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2015
3	CytokinesIBA 12/2022 - 09/2009
3	Biological ProductsIBA 08/2021 - 07/2011
3	RelaxinIBA 11/2019 - 01/2013
3	Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2017
3	EnzymesIBA 11/2016 - 06/2008
3	Amyloid (Amyloid Fibrils)IBA 10/2016 - 11/2006
3	Amyloid beta-PeptidesIBA 10/2016 - 05/2005
3	navitoclaxIBA 02/2016 - 01/2013
3	InterferonsIBA 04/2015 - 12/2011
3	Small Interfering RNA (siRNA)IBA 01/2013 - 12/2006
2	NucleosidesIBA 01/2022 - 06/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2018
2	pyrimidineIBA 01/2022 - 06/2021
2	remdesivirIBA 01/2022 - 06/2021
2	LipidsIBA 12/2021 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 08/2015
2	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2018
2	LuciferasesIBA 03/2020 - 01/2013
2	DystrophinIBA 01/2020 - 01/2017
2	AntigensIBA 01/2020 - 12/2016
2	Histones (Histone)IBA 11/2019 - 01/2019
2	Therapeutic UsesIBA 11/2019 - 01/2015
2	Growth Differentiation Factor 15IBA 10/2019 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2018
2	metarrestinIBA 12/2018 - 01/2018
2	Cocaine (Cocaine HCl)IBA 01/2018 - 04/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 01/2017
2	trametinibIBA 01/2018 - 01/2018
2	BenzodiazepinesIBA 04/2017 - 12/2010
2	AcidsIBA 01/2017 - 09/2012
2	ChromatinIBA 01/2017 - 11/2008
2	TOR Serine-Threonine KinasesIBA 01/2017 - 03/2015
2	Estrogen Receptor alphaIBA 12/2016 - 12/2003
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 06/2012
2	GalactosylceramidaseIBA 11/2016 - 03/2013
2	propylene diquat (PDQ(+))IBA 09/2016 - 03/2012
2	CateninsIBA 05/2016 - 01/2013
2	chlorcyclizineIBA 02/2016 - 04/2015
2	ruxolitinibIBA 02/2016 - 10/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2014 - 01/2013
2	Lysergic Acid Diethylamide (LSD)IBA 09/2012 - 01/2011
2	Insulin (Novolin)FDA Link 01/2012 - 03/2009
2	LipopolysaccharidesIBA 12/2011 - 09/2009
1	ProteomeIBA 12/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	pyrrolopyrimidineIBA 01/2022
1	carfilzomibIBA 01/2022
1	PanobinostatIBA 01/2022
1	molnupiravirIBA 01/2022

Therapy/Procedure

31	Therapeutics 01/2022 - 12/2003
8	Drug Therapy (Chemotherapy) 06/2020 - 06/2012
3	Percutaneous Coronary Intervention 01/2019 - 12/2017
2	Immunotherapy 01/2020 - 12/2016
1	Ultrasonic Therapy 01/2022